Although serum S100B might be associated with other conditions such as blood-brain barrier disruption, weight changes or neurological diseases, S100B changes in schizophrenia are lower than would be expected in neurological diseases with brain injury (Schroeter et al., 2009; Steiner et al., 2010b). The gene discussed is S100B; the disease is nervous system disorder.